Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8226945 Antibodies and immunoconjugates and uses therefor

Patent 8226945 was granted and assigned to Genentech on July, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

82269450

Patent Inventor Names

Allen J. Ebens, Jr.0

Shang-Fan Yu0

Wei-Ching Liang0

Yan Wu0

Alane M. Gray0

Date of Patent

July 24, 2012

Patent Application Number

129395330

Date Filed

November 4, 2010

Patent Citations Received

‌

US Patent 12102689 Anti-CD22 antibody-maytansine conjugates and methods of use thereof

‌

US Patent 11692041 Antibody molecules which bind CD45

‌

US Patent 11872289 Anti-MUC1 antibody-drug conjugate

‌

US Patent 11890354 Activatable antibodies that bind epidermal growth factor receptor and methods thereof

‌

US Patent 11945882 Method for producing antibody-drug conjugate

Patent Primary Examiner

‌

Phuong Huynh

Patent abstract

Anti-CD22 antibodies and immunoconjugates thereof are provided. Methods of using anti-CD22 antibodies and immunoconjugates thereof are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8226945 Antibodies and immunoconjugates and uses therefor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API